Table 3.
Comparison of clinical pregnancy outcomes between the two groups.
| GROUP A (n = 160)a | GROUP B (n = 181)b | Two-tailed P value | |
|---|---|---|---|
| Clinical outcome (%) | |||
| Clinical pregnancy | 65/160 (40.63) | 77/181 (42.54) | 0.72 |
| Biochemical pregnancy rate | 22/160 (13.75) | 20/181 (11.05) | 0.45 |
| Clinical miscarriage rate | 27/65 (41.54) | 34/77 (44.16) | 0.75 |
| Ectopic pregnancy | 2/65 (3.08) | 3/77 (3.90) | 1c |
| Live birth rate | 38/160 (23.75) | 43/181 (23.75) | 0.74 |
| Preterm birth | 5/160 (3.12) | 5/181 (2.76) | 0.84 |
| Full-term birth | 33/160 (20.63) | 38/181 (20.99) | 0.95 |
aIn the study group (n = 160), GnRH-a was added based on GnRH-a before hormone administration to adjust the menstruation cycle.
bThe control group (n = 181) was treated only with an artificial hormone cycle to prepare the endometrium.
cThis value was calculated by means of Fisher’s exact test.